Full article available online at Healio.com/Orthopedics. Search: 20140401-55 Data on the relationship between osteoporosis and osteoarthritis are conflicting. Most studies report "snapshot" prevalences, and there are few studies evaluating localized knee bone mineral density (BMD) measurements with respect to subsequent osteoarthritis progression. The authors hypothesize that increased mediolateral difference of the proximal tibial BMD may predict progression of knee osteoarthritis. In this study, 246 female volunteers were followed up prospectively over 2 years. Baseline BMD measurements of bilateral proximal (subchondral) tibiae were performed, and the mediolateral BMD ratio was calculated. Precision studies were performed on healthy volunteers to validate the technique. The patients were divided into osteoarthritis progressors and non-progressors based on Kellgren-Lawrence radiographic criteria at 2-year follow-up. Patients who were taking bisphosphonates or who had a history of inflammatory, infectious, or metabolic bone disease and previous hip and knee surgery were excluded. Demographic data, calcium supplementation, physical activity, baseline knee radiographs, and radiographs at 2-year follow-up were obtained. The study was adequately powered to detect an effect size of 0.4. There were 121 progressors and 125 non-progressors. Mean mediolateral BMD ratio was 1.02 among the progressors and 1.01 among the non-progressors (t=0.632, P=.528). Potential confounders were equally distributed among both groups. The data suggest that there is no link between proximal tibial BMD ratio and progression of knee osteoarthritis.
O steoporosis and osteoarthritis have become significant contributors to the global burden of disease, particularly with aging populations and increases in life expectancy. In Asia, the prevalence of knee osteoarthritis was 7.9% in a pooled sample of 41,884 patients from 11 community-oriented program for the control of rheumatic diseases (COPCORD) studies. 1 The prevalence was 16.7% among adults aged more than 45 years in the Johnston county study and 12.6% among adults in the National Health and Nutrition Examination Survey III study. 1, 2 In Europe, osteoporosis contributes significantly to total disabilityadjusted life years. 3 In the United States, 54% of postmenopausal white women have osteopenia and 30% have osteoporosis, and at age 80 years, 27% have osteopenia and 70% have osteoporosis. 4 With the rising prevalence of osteoporosis and osteoarthritis, the relationship between these two conditions becomes increasingly important. Understanding the relationship between osteoporosis and osteoarthritis may provide a better understanding of the predictors of osteoarthritis progression and perhaps an improved management strategy for osteoarthritis, focusing on prevention rather than symptom control and salvage surgery. The association between osteoporosis and osteoarthritis remains poorly understood at the clinical, radiologic, histomorphometric, and molecular levels. Tanck et al 5 reported increased anisotropy of the femoral head trabeculae in patients with osteoporosis and fractures compared with patients with osteoarthritis. At the molecular level, the role of inflammation has been suggested in the pathophysiology of both disease processes, but the inflammatory cytokine profiles in the 2 diseases appear to be different. Zupan et al 6 reported that the relationship between osteoclastogenic and anti-osteoclastogenic proinflammatory cytokines differs in human bone tissue with osteoporosis and osteoarthritis, corresponding to the specific bone phenotypes. Martinez-Calatrava et al 7 suggested that chondrocyte-synthesized receptor activator of nuclear factor kappa-B ligand (RANKL) may contribute to the development of juxta-articular osteoporosis associated with chronic arthritis by enhancing osteoclastogenesis.
Although the relationship between osteoarthritis and osteoporosis remains controversial, it appears that these two conditions seldom occur together. Numerous reports [8] [9] [10] [11] [12] [13] have shown an inverse relationship between osteoporosis and osteoarthritis. Patients with higher bone mineral density (BMD) are akin to "bone farmers," producing more osteophytes, whereas those with low BMD are "bone absorbers," with subchondral collapse that results in osteoarthritis. In addition to systemic BMD, the ratio of medial to lateral subchondral tibia BMD has been reported to be associated with risk factors for progression of osteoarthritis, including static alignment and dynamic alignment. 14, 15 The goal of this study was to evaluate whether the baseline mediolateral tibial BMD ratio predicts the progression of osteoarthritis at 2-year follow-up. The authors hypothesize that an increased baseline mediolateral difference in subchondral tibial BMD may predict progression of knee osteoarthritis. A mediolateral BMD difference of 4% must be present to The subjects were asked to lie supine on the scan table and the feet were positioned upright with a jig, allowing the patella to face upward (A). The start of the site of measurement was 2 cm above the superior pole of the patella (laser mark) (B).
A B Figure 2:
Each region of interest (ROI) was manually positioned in the medial and lateral compartments of the subchondral tibial bone. Each ROI was 5 mm in height and was defined within 2 rectangles 10 mm distal to the tip of the tibial intercondylar spine, which was used as a reference point, either medially or laterally to the edge of the scanned image.
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identify the baseline BMD ratio as a clinically important variable for distinguishing between patients who had osteoarthritis progression (progressors) and those who did not (non-progressors). This observation is based on preliminary data that showed a standard deviation of 10% in the BMD ratio.
Materials and Methods
Volunteers were recruited at the study institution between 2006 and 2009. Community ambulant female patients without a history of knee pain, instability, or other symptoms, such as locking, were recruited. Patients were excluded from the study if they had a history of metabolic bone disease; lower limb fracture; inflammatory, infectious, or neuropathic arthropathy; previous hip or knee surgery; or bisphosphonate use. The study population was divided into 2 groups: osteoarthritis progressors and non-progressors, based on radiographic evidence of osteoarthritis progression at 2-year follow-up. The proportion of pre-and postmenopausal women was equal in both groups. Participants considered pre-and postmenopausal were women aged 45 to 47 years with regular menses during the 2 years before study entry and women aged 55 to 60 years with cessation of menses for at least 12 months, respectively. The study was approved by the institutional review board and hospital ethics committee, and written informed consent was obtained from all patients. To eliminate ethnicity as a confounding variable, only Chinese women were included in the sample.
Data recorded on each subject included age, anthropometric characteristics, and use of calcium supplements. Patients' physical activity levels were assessed by the international physical activity questionnaire.
Each subject underwent baseline bilateral standing anteroposterior radiographic knee examination on recruitment. Knee radiographs were repeated at the 2nd-year follow-up. Baseline femoral neck and proximal tibial BMD measurements were performed.
Measurement of Subchondral Tibial Bone Mineral Density
The BMD of bilateral femur necks and bilateral medial tibial subchondral bones was determined using a Norland XR-46 (Cooper Surgical, Fort Atkinson, Wisconsin) dual-energy x-ray absorptiometry scanner. The precision of bone density measurement is important when the technique is being used to follow changes in bone density over time. To validate the technique and determine the reproducibility in tibia subchondral BMD measurements, a precision study was performed. Fifteen healthy volunteers aged 22 to 55 years (all women, mean age 42.3±11 years) had BMD of the left knee measured 3 times on the same day. The subjects were asked to lie supine on the scan table and the feet were positioned upright with a jig, allowing the patella to face upward (Figure 1) . The start of the site of measurement was 2 cm above the superior pole of the patella. Scans were performed at a speed of 60 mm/s and resolution of 1×1 mm. Regions of interest were manually positioned in the medial and lateral compartments of the subchondral tibial bone. Each region of interest was 5 mm high and was defined within 2 rectangles 15 mm distal to the tip of the tibial intercondylar spine, which was used as a reference point, either medially or laterally to the edge of the scanned image (Figure 2 ). Subjects were required to get off the table, and the knee was repositioned after each scan. All of the scans were performed by the same technician. To further validate this method, BMD measurements were also performed for the femoral neck in these patients.
Precision error is a measure of the reproducibility of BMD at an anatomic region and is expressed as a standard deviation in grams per centimeters squared or as a percent coefficient of variation. The coefficients of variation of BMD were calculated and reported ( Table 1) . There was no difficulty in positioning of the knee using the jig because the subjects were able to extend the knee fully. When the subjects were repositioned for the repeat scan, care was taken to ensure that the positioning was consistent with the baseline scan.
All baseline and 2nd-year knee radiographs were graded by 2 independent observers on the presence or absence of osteophytes and joint space narrowing according to the Kellgren-Lawrence scale (grades 0-4). The worse value on the Kellgren-Lawrence scale from either knee was reported for that particular followup. Knee osteoarthritis was considered to have progressed if the Kellgren-Lawrence scale value was higher on the 2nd-year follow-up radiographs.
Statistical Analysis
Study design followed sample size estimation using G*Power version 3.
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The study was adequately powered to detect an effect size of 0.4. Additionally, the α error probability was 0.05 and 80% power. To achieve this power, each group needed to have 100 patients. The authors sampled 283 patients and had a sample size of 246 patients after those lost to follow-up were excluded; 121 patients were included in the group that had progression of osteoarthritis and 125 were included in the group that had no progression of osteoarthritis.
Categorical variables are shown as percentages and compared using chi-square/ Fisher's exact test. Continuous variables are presented as mean±standard deviation and comparisons were made by use of the independent samples t test, the null hypothesis being that there is no difference in baseline mediolateral tibial BMD ratio between the two groups. Levene's test for equality of variances was performed. Precision was calculated as the coefficient of variation defined as standard deviation/mean. 
results

Validation of the Measurement Technique
The least significant change was defined as the minimum amount of change needed to be 95% confident that the change in BMD was not due to random measurement error. The precision error of femoral neck BMD measurement in the authors' laboratory was 0.015 g/cm 2 , and the least significant change at the 95% confidence interval was 4.2%. The precision error is expected to be higher in tibial subchondral BMD measurement because the area measured is smaller. In this study, the precision error in knee BMD measurement was 0.009 g/cm 2 for medial tibial BMD and 0.017 g/cm 2 for lateral tibial BMD. The least significant change was 2.4% for the medial tibia and 4.8% for the lateral tibia. The coefficient of variation was 1.04% for the medial tibia and 2.26% for the lateral tibia ( Table 1) . This was comparable to the precision in the femoral neck, which confirms good reproducibility of the technique in measuring knee BMD.
Demographics of the Patient Cohort and Distribution of Potential Confounders
After exclusion of patients lost to follow-up, there were 246 patients with mean age 50.60±5.65 years. There were 121 patients in the group with osteoarthritis progression and 125 patients in the group with no progression. Duration of mean follow-up was 771 days. The distribution of confounding factors was not significantly different among the 2 groups. These included age (t=0.170, P=.865), body mass index (t=0.852, P=.395), Table 1 Reproducibility physical activity (t=-1.101, P=.272), and calcium supplementation (P=.698). The difference in menopausal status among both groups was not statistically significant (P=.698)
Proximal Tibial Mediolateral Bone Mineral Density Ratios
The mean baseline mediolateral tibial BMD ratio among progressors and non-progressors was 1.02±0.097 and 1.01±0.11, respectively. This difference was not statistically significant (t=0.632, P=.528). The data are shown in Table 2 .
discussion
Most studies evaluating the relationship between osteoporosis and osteoarthritis tend to report on a "snapshot" prevalence of BMD and osteoarthritis, and few studies have evaluated localized BMD measurements in the knee and subsequent progression of osteoarthritis. Another issue with localized BMD measurements is the precision of the technique. Hulet et al 18 reported reproducibility of 2.9%, whereas Clarke et al 19 reported 7%. This study achieved precision of 1.04% and 2.26% for medial and lateral subchondral tibia BMD, respectively. In addition, the authors correlated the measurements of subchondral tibial BMD and femoral neck BMD. This study was adequately powered to detect a clinically significant difference in proximal tibial BMD ratios between the 2 groups. A post hoc power calculation between the 2 groups showed that the study achieved a power of 87.7%.
The authors postulate that patients with progression of knee osteoarthritis should have high proximal tibial mediolateral BMD ratios and vice versa. Radin et al 20 and Radin and Rose 21 postulated that the health of the articular cartilage is associated with the condition of the underlying subchondral bone. A stiff subchondral bone, with resulting loss of compliance, transmits stress onto the overlying articular cartilage. An osteoporotic subchondral bone can function as a shock absorber and reduce load on the overlying cartilage. It is believed that patients with higher BMD are "bone farmers," with a higher tendency to form osteophytes. Dequeker et al 22 also showed increased insulin-like growth factor and transforming growth factor beta in patients with hand osteoarthritis, suggesting increased activity of osteoblasts. As such, high tibial BMD should theoretically predict for osteoarthritis and progression of osteoarthritis. On the other hand, high tibial BMD may be secondary to microfracture and collapse of subchondral bone in varus knee osteoarthritis. According to Wolff's law, 23 the increased loading of the medial compartment in knee osteoarthritis might stimulate bone remodeling, resulting in a higher medial compartment BMD. However, clinically, a significant difference was not seen between knee osteoarthritis progressors and non-progressors with respect to baseline proximal tibial mediolateral BMD ratios at 2-year follow-up.
Proximal tibial changes secondary to knee osteoarthritis may provide a reference for assessment of knee osteoarthritis as well as prediction of progression of osteoarthritis. Subchondral cysts and subchondral sclerosis associated with knee osteoarthritis will inevitably affect BMD measurement. Stiff subchondral tibial bone transmits stress onto the overlying cartilage, accelerating the progression of osteoarthritis. 20, 21 Lo et al 24 showed that meniscal damage is associated with higher regional tibial BMD in the same compartment. Progression of deformity of the knee (varus or valgus) also positively correlated with the mediolateral difference of proximal tibia density. Meniscal damage and increasing deformity of the knee, with resulting asymmetrical loading of the knee, would lead to progression of knee osteoarthritis. It was postulated that mediolateral tibial subchondral BMD could be a significant predictor of progression of knee osteoarthritis. However, the findings of this study showed no significant statistical correlation of mediolateral tibial subchondral BMD with progression of knee osteoarthritis.
There was a small mediolateral subchondral tibia BMD difference in most of the study patients, resulting in a ratio of almost 1 in most of the cohort. Most of the patients in the current study had mild knee osteoarthritis, with only 5 patients with Kellgren-Lawrence grade 3 knee osteoarthritis and no patients with grade 4 knee osteoarthritis. Knee deformity was also predictably less severe in this study population. This represents a limitation of the study. Nevertheless, this study was adequately powered, with 2 subgroups of patients (progressors and non-progressors) and almost equal numbers of patients in each group. Among the progressors, there was at least 1 grade of osteoarthritis progression according to the Kellgren-Lawrence grading system verified by 2 independent observers.
conclusion
The current study results do not suggest an association between subchondral n Feature Article 
